Opportunities and challenges in stem cell therapy in cardiovascular diseases: Position standing in 2022.
Bone marrow
Cardiac diseases
Clinical trials
MSCs
Pre-clinical trials
Stem cell therapy
iPSCs
Journal
Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society
ISSN: 1319-0164
Titre abrégé: Saudi Pharm J
Pays: Saudi Arabia
ID NLM: 9705695
Informations de publication
Date de publication:
Sep 2022
Sep 2022
Historique:
received:
12
02
2022
accepted:
17
06
2022
entrez:
17
10
2022
pubmed:
18
10
2022
medline:
18
10
2022
Statut:
ppublish
Résumé
This study intends to evaluate the development, importance, pre-clinical and clinical study evaluation of stem cell therapy for the treatment of cardiovascular disease. Cardiovascular disease is one of the main causes of fatality in the whole world. Though there are great progressions in the pharmacological and other interventional treatment options, heart diseases remain a common disorder that causes long-term warnings. Recent accession promotes the symptoms and slows down the adverse effects regarding cardiac remodelling. But they cannot locate the problems of immutable loss of cardiac tissues. In this case, stem cell treatment holds a promising challenge. Stem cells are the cells that are capable of differentiating into many cells according to their needs. So, it is assumed that these cells can distinguish into many cells and if these cells can be individualized into cardiac cells then they can be used to replace the damaged tissues of the heart. There is some abridgment in this therapy, none the less stem cell therapy remains a hopeful destination in the treatment of heart disease.
Identifiants
pubmed: 36249945
doi: 10.1016/j.jsps.2022.06.017
pii: S1319-0164(22)00165-7
pmc: PMC9563042
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
1360-1371Informations de copyright
© 2022 The Author(s).
Déclaration de conflit d'intérêts
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
Br J Ophthalmol. 2017 Nov;101(11):1583-1590
pubmed: 28844046
Nature. 2008 Feb 21;451(7181):937-42
pubmed: 18288183
Interact Cardiovasc Thorac Surg. 2014 Jan;18(1):61-6
pubmed: 24130088
Circ Res. 2008 Nov 21;103(11):1204-19
pubmed: 19028920
Front Biosci (Landmark Ed). 2011 Jun 01;16(6):2271-88
pubmed: 21622176
Circ Res. 2015 Apr 10;116(8):1413-30
pubmed: 25858066
Nat Clin Pract Cardiovasc Med. 2007 Feb;4 Suppl 1:S27-39
pubmed: 17230213
Card Electrophysiol Clin. 2015 Jun;7(2):357-70
pubmed: 26002399
Circ Res. 2015 Sep 25;117(8):695-706
pubmed: 26228030
Regul Pept. 2004 Jan 15;117(1):3-10
pubmed: 14687695
Circ Res. 2004 Oct 29;95(9):911-21
pubmed: 15472116
Proc Natl Acad Sci U S A. 2007 Aug 28;104(35):14068-73
pubmed: 17709737
Stem Cells Int. 2013;2013:658480
pubmed: 23737803
Physiol Rev. 2016 Jul;96(3):1127-68
pubmed: 27335447
Nature. 2013 Jan 17;493(7432):433-6
pubmed: 23222518
Oncotarget. 2017 Sep 8;8(43):75756-75766
pubmed: 29088907
Stem Cells. 2009 Sep;27(9):2126-35
pubmed: 19521979
Eur Heart J. 2009 Dec;30(24):2978-84
pubmed: 19773226
Ann Thorac Surg. 2009 Mar;87(3):794-801
pubmed: 19231391
J Card Fail. 2010 Apr;16(4):357-66
pubmed: 20350704
Nature. 2001 Apr 5;410(6829):701-5
pubmed: 11287958
Circulation. 2017 Sep 19;136(12):1123-1139
pubmed: 28733351
Mol Ther Nucleic Acids. 2020 Mar 6;19:421-436
pubmed: 31896070
Circ Res. 2018 Feb 2;122(3):479-488
pubmed: 29208679
Stem Cells Dev. 2012 Oct 10;21(15):2798-808
pubmed: 22530853
Eur Heart J. 2014 May 14;35(19):1263-74
pubmed: 24497345
Circ Res. 2015 Mar 27;116(7):e40-50
pubmed: 25654979
Cell. 2006 Aug 25;126(4):663-76
pubmed: 16904174
Stem Cells. 2012 Jan;30(1):33-41
pubmed: 22213481
J Am Coll Cardiol. 2014 Jan 21;63(2):110-22
pubmed: 24036024
Lancet. 2011 Nov 26;378(9806):1847-57
pubmed: 22088800
Trials. 2012 Jul 02;13:99
pubmed: 22747980
Int J Stem Cells. 2018 May 30;11(1):1-12
pubmed: 29482311
Int J Mol Med. 2016 Jul;38(1):23-9
pubmed: 27220939
JAMA Cardiol. 2016 Oct 1;1(7):831-841
pubmed: 27557438
Circ Res. 2018 Mar 30;122(7):1006-1020
pubmed: 29599277
Am J Respir Cell Mol Biol. 2021 Nov;65(5):473-488
pubmed: 34293272
Nat Commun. 2014 May 30;5:4000
pubmed: 24873804
Ann Thorac Surg. 2002 Jun;73(6):1919-25; discussion 1926
pubmed: 12078791
PLoS One. 2011 Apr 28;6(4):e19012
pubmed: 21552563
Cell Physiol Biochem. 2018;48(6):2607-2655
pubmed: 30121644
Clin Transl Med. 2016 Dec;5(1):34
pubmed: 27539581
Philos Trans R Soc Lond B Biol Sci. 2013 Jan 5;368(1609):20110334
pubmed: 23166396
J Appl Genet. 2007;48(4):307-19
pubmed: 17998587
Rev Esp Cardiol. 2009 Sep;62(9):1032-44
pubmed: 19712624
Am Heart J. 2014 Jul;168(1):88-95.e2
pubmed: 24952864
J Am Coll Cardiol. 2015 Nov 3;66(18):1990-1999
pubmed: 26516002
Circ Res. 2017 Mar 31;120(7):1162-1173
pubmed: 28052915
Nat Biotechnol. 2000 Apr;18(4):399-404
pubmed: 10748519
Beilstein J Nanotechnol. 2021 Aug 2;12:786-797
pubmed: 34395152
Cardiology. 2009;113(3):155-60
pubmed: 19122455
Circ Res. 2013 Apr 26;112(9):1202-4
pubmed: 23620232
Cytotherapy. 2006;8(4):315-7
pubmed: 16923606
Eur Heart J. 2008 Jan;29(2):251-9
pubmed: 18073226
Int J Mol Sci. 2020 Mar 29;21(7):
pubmed: 32235313
Circ Res. 2014 Apr 11;114(8):1292-301
pubmed: 24449819
J Am Coll Cardiol. 2011 Jan 25;57(4):455-65
pubmed: 21251587
Mol Ther Nucleic Acids. 2021 Jul 02;26:135-147
pubmed: 34513300
Eur Heart J. 2007 Sep;28(17):2174-5; author reply 2175
pubmed: 17673446
JAMA. 2012 Dec 12;308(22):2369-79
pubmed: 23117550
Circ Res. 2004 Aug 20;95(4):343-53
pubmed: 15321944
Atherosclerosis. 2010 Mar;209(1):10-7
pubmed: 19740466
Expert Rev Mol Med. 2009 Jul 08;11:e20
pubmed: 19586557
Sci Rep. 2016 Jun 20;6:28250
pubmed: 27321050
Clin Res Cardiol. 2011 Oct;100(10):925-34
pubmed: 21633921
Circ Res. 2018 Jun 22;123(1):9-11
pubmed: 29929968
Biomed Pharmacother. 2020 Dec;132:110813
pubmed: 33068940
Lancet. 2012 Mar 10;379(9819):895-904
pubmed: 22336189
Curr Opin Cell Biol. 2021 Dec;73:92-104
pubmed: 34384976
EMBO J. 2020 Oct 15;39(20):e105578
pubmed: 33058248
Front Pharmacol. 2015 Oct 21;6:227
pubmed: 26539113
J Am Coll Cardiol. 2010 Mar 30;55(13):1385-94
pubmed: 20338501
Cell Rep Med. 2021 Apr 20;2(4):100251
pubmed: 33948581
J Mol Cell Cardiol. 2008 Mar;44(3):486-95
pubmed: 18061611
JACC Basic Transl Sci. 2016 Oct;1(6):510-523
pubmed: 28580434
Cardiovasc Res. 2020 Jul 1;116(8):1424-1433
pubmed: 32022845
PLoS One. 2021 Feb 26;16(2):e0247381
pubmed: 33635873
J Cell Biochem. 2006 Aug 1;98(5):1076-84
pubmed: 16619257
Br J Pharmacol. 2013 May;169(2):247-68
pubmed: 22712727
Cell. 2003 Sep 19;114(6):763-76
pubmed: 14505575
N Engl J Med. 2006 Sep 21;355(12):1199-209
pubmed: 16990383
FASEB J. 2007 May;21(7):1345-57
pubmed: 17284483
Stem Cells Transl Med. 2014 Feb;3(2):183-93
pubmed: 24371329
Future Cardiol. 2020 May;16(3):199-209
pubmed: 32125173
Cardiovasc Res. 1987 Oct;21(10):737-46
pubmed: 3440266
Regen Med. 2011 Jul;6(4):481-92
pubmed: 21749206
J Gerontol B Psychol Sci Soc Sci. 2020 Sep 14;75(8):e174-e188
pubmed: 32507890